Engineered variant of recombinant human fibroblast growth factor 19

Engineered variant of recombinant human fibroblast growth factor 19
Trade Name
Orphan Indication Primary biliary cirrhosis
USA Market Approval USA
USA Designation Date 2014-02-06 00:00:00
Sponsor NGM Biopharmaceuticals, Inc.;630 Gateway Blvd;South San Francisco, California, 94080